Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Phase of Trial: Phase II
Latest Information Update: 02 Oct 2017
At a glance
- Drugs Lonafarnib (Primary) ; Ritonavir
- Indications Hepatitis D
- Focus Adverse reactions; Therapeutic Use
- Acronyms LOWR HDV - 3
- 02 Oct 2017 According to an Eiger BioPharmaceuticals, Inc. media release, study and mathematical modeling designed to inform next steps in clinical development will be presented at the American Association for the Study of Liver Diseases (AASLD) 2017.
- 21 Apr 2017 According to an Eiger BioPharmaceuticals, Inc. media release, data from the study has been presented at the The International Liver Congress 2017.
- 21 Apr 2017 Results from the LOWER HDV program published in an Eiger BioPharmaceuticals, Inc. media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History